AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,134.00p
   
  • Change Today:
    -38.00p
  • 52 Week High: 12,370.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.24m
  • Volume: 86,138
  • Market Cap: £188,106m
  • RiskGrade: 123

Latest ShareCast News

Sector movers: Aerospace and Defence, Pharma pace gains

By Alexander Bueso

Date: Wednesday 08 May 2024

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

London close: Stocks rise further ahead of BoE decision

By Josh White

Date: Wednesday 08 May 2024

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Berenberg hikes target price on Astrazeneca

By Iain Gilbert

Date: Tuesday 07 May 2024

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

AstraZeneca reports positive results from blood ... 02-May-2024 ShareCast
AstraZeneca makes progress with two breast cance... 29-Apr-2024 ShareCast
London close: Stocks finish mixed as US GDP grow... 25-Apr-2024 ShareCast
AstraZeneca blows past analysts' estimates for Q1 25-Apr-2024 ShareCast
London close: Stocks finish lower as ECB stands ... 11-Apr-2024 ShareCast
AstraZeneca to hike 2024 dividend by 7% 11-Apr-2024 ShareCast
AstraZeneca's Enhurtu cancer gets US green light... 08-Apr-2024 ShareCast
AstraZeneca announces positive lung cancer treat... 05-Apr-2024 ShareCast
US FDA gives green light for use of AstraZeneca'... 02-Apr-2024 ShareCast
London close: Stocks turn red on return from Eas... 02-Apr-2024 ShareCast
AstraZeneca gets FDA approval for Ultomiris trea... 25-Mar-2024 ShareCast
AstraZeneca to buy US-listed Fusion Pharma for $... 19-Mar-2024 ShareCast
AstraZeneca snaps up rare disease specialist Amo... 14-Mar-2024 ShareCast
AstraZeneca's chemo replacement treatment moves ... 04-Mar-2024 ShareCast
AstraZeneca's blood-disorder drug recommended fo... 26-Feb-2024 ShareCast
AstraZeneca acquires US-based biopharmaceutical ... 20-Feb-2024 ShareCast
London close: Stocks manage gains on globally qu... 19-Feb-2024 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,134.00p
Change Today -38.00p
% Change -0.31 %
52 Week High 12,370.00
52 Week Low 9,501.00
Volume 86,138
Shares Issued 1,550.24m
Market Cap £188,106m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.48% below the market average92.48% below the market average92.48% below the market average92.48% below the market average92.48% below the market average
92.16% below the sector average92.16% below the sector average92.16% below the sector average92.16% below the sector average92.16% below the sector average
Price Trend
59.08% above the market average59.08% above the market average59.08% above the market average59.08% above the market average59.08% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Income
91.19% below the market average91.19% below the market average91.19% below the market average91.19% below the market average91.19% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
82.60% above the market average82.60% above the market average82.60% above the market average82.60% above the market average82.60% above the market average
94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average

What The Brokers Say

Strong Buy 8
Buy 15
Neutral 5
Sell 0
Strong Sell 1
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 22-Feb-24 10-Aug-23
Paid 25-Mar-24 11-Sep-23
Amount 197.00¢ 93.00¢

Trades for 16-May-2024

Time Volume / Share Price
08:39 28 @ 12,134.00p
08:39 24 @ 12,134.00p
08:39 77 @ 12,134.00p
08:39 9 @ 12,132.00p
08:39 13 @ 12,132.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page